Scigenomics has tied up with TQ Wellness to bring out the best health supplements for the benefit of the consumers and show them a way of bringing an upgrade in their Scigenomics has tied up with Meditek Futuro which offers facilities in the field of Stem Cells.
Our only aim behind this initiative is to bring to you the new age medical treatments and facilities which are not only safe but also are promising enough to be relied on and trusted on. We include specialized cultured cells originating from bone marrow known as neural precursor cells, which are specifically designed for neurodegenerative conditions such as MND, Autism, Spinal Cord Injury, and Cerebral Palsy. The stem-cell source can be autologous (derived from the patient) or allogeneic (derived from the donor). For an autologous operation, we would need 60 ml of bone marrow from the patient's iliac crest.
These neural precursor tissues stimulate neurogenesis, or the development of new nerve cells, which gives birth to nerves and thereby initiates the healing process. Stem-cell therapies have emerged as a newly found treatment that has been successfully modified into being a regenerative medicine to treat various disorders that were not curable earlier.
Medical Sciences is making advancements and with every single change, Scigenomics wants to be at your service in the best, swift, and accessible manner. As patients, your concerns will be understood and be catered to in the best manner possible as the medical professionals working here are very dedicated and efficient in their jobs to provide you with the best treatment.
what is whole genome sequencing ?
Whole-genome sequencing has become a valuable method for genomics research due to rapidly falling sequence procedure costs and the capacity of today's sequencers to yield vast quantities of data. WGS is a process for examining whole genomes. Classification of genetic illnesses, characterising the genes that cause cancer development, and monitoring disease outbreaks have all benefited from genomic knowledge.